SILEXION THERAPEUTICS CORP Increase (Decrease) in Other Current Assets
SILEXION THERAPEUTICS CORP (SLXN) reported Increase (Decrease) in Other Current Assets of $15.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-14
- SILEXION THERAPEUTICS CORP increase (decrease) in other current assets for the quarter ending 2026-06-30 was $15.00K, a 200.00% increase year-over-year.
- SILEXION THERAPEUTICS CORP increase (decrease) in other current assets for the quarter ending 2026-03-31 was $47.00K.
- SILEXION THERAPEUTICS CORP increase (decrease) in other current assets for the quarter ending 2025-12-31 was $2.00K.
- SILEXION THERAPEUTICS CORP increase (decrease) in other current assets for the quarter ending 2025-09-30 was -$16.00K, a 194.12% decline year-over-year.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $15.00K 10-Q · filed 2026-08-14 | $62.00K 10-Q · filed 2026-08-14 | $64.00K derived: sum of 3 quarters · filed 2026-08-14 | $48.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $47.00K S-1/A · filed 2026-08-10 | $49.00K derived: sum of 2 quarters · filed 2026-08-10 | $33.00K derived: sum of 3 quarters · filed 2026-08-10 | $38.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $2.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | -$14.00K derived: sum of 2 quarters · filed 2026-08-10 | -$9.00K derived: sum of 3 quarters · filed 2026-08-14 | -$13.00K S-1/A · filed 2026-08-10 |
| 2025-09-30 | -$16.00K 10-Q · filed 2025-11-12 | -$11.00K derived: sum of 2 quarters · filed 2026-08-14 | -$15.00K 10-Q · filed 2025-11-12 | -$36.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $5.00K 10-Q · filed 2026-08-14 | $1.00K 10-Q · filed 2026-08-14 | -$20.00K derived: sum of 3 quarters · filed 2026-08-14 | -$3.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$4.00K S-1/A · filed 2026-08-10 | -$25.00K derived: sum of 2 quarters · filed 2026-08-10 | -$8.00K derived: sum of 3 quarters · filed 2026-08-10 | -$10.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2024-12-31 | -$21.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | -$4.00K derived: sum of 2 quarters · filed 2026-08-10 | -$6.00K derived: sum of 3 quarters · filed 2026-08-10 | $38.00K S-1/A · filed 2026-08-10 |
| 2024-09-30 | $17.00K 10-Q · filed 2025-11-12 | $15.00K derived: sum of 2 quarters · filed 2025-11-12 | $59.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$2.00K 10-Q · filed 2025-08-12 | $42.00K 10-Q · filed 2025-08-12 | ||
| 2023-12-31 | -$18.00K 8-K · filed 2025-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |